Dianthus Therapeutics is positioned as a category-expanding biotech, leveraging convenience and safety. Find out why DNTH stock is a buy.

Executive Hires and Changes -- Appointed David Wambeke as Chief Business Officer and announced CFO transition to Christopher ...

Infantino, who is wary of unstructured interactions with the press, narrowed his eyes and considered. “Very good,” he replied ...

COM701 MAIA-ovarian trial actively enrolling patients across all clinical sites in the U.S., Israel, and France; interim analysis on track by Q1 2027 Partner AstraZeneca ...

The journeys to Colle Bereto, a swish cafe in the centre of Florence, were always filled with chatter when Mohamed Salah was ...

The latest Nintendo Download update for North America arrived yesterday, bringing new games galore to the eShop. As always, ...

The journeys to Colle Bereto, a swish cafe in the centre of Florence, were always filled with chatter when Mohamed Salah was ...

A reboot might not have made sense but it's what many people wanted Bungie Destiny Destiny 3 Bungie currently has no plans to work on a Destiny 3, according to a new report by Bloomberg. While new ...

Bungie has announced the end of content updates for live service shooter Destiny 2, nearly nine years after launch. The studio behind Halo, which recently released extraction shooter Marathon, said it ...

Forbes contributors publish independent expert analyses and insights. News and opinion about video games, television, movies and the internet. This voice experience is generated by AI. Learn more.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Destiny 2 players were stunned yesterday when Bungie said it was ending development on the ...

This week, Bungie confirmed what many in the Destiny community feared. Destiny 2 will not continue past the upcoming June update, and the franchise’s future as a whole seems cloudy at best. Bungie ...